SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    A-Jin Lee, Chang Hyeong Lee, Chang-Ho Jeon, Analysis of Reverse Transcriptase Gene Mutations in the Hepatitis B Virus at a University Hospital in Korea, Annals of Laboratory Medicine, 2014, 34, 3, 230

    CrossRef

  2. 2
    Giovanni Galati, Antonio De Vincentis, Umberto Vespasiani-Gentilucci, Paolo Gallo, Donatella Vincenti, Maria Solmone, Chiara Dell’Unto, Antonio Picardi, Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination, BMC Gastroenterology, 2014, 14, 1, 94

    CrossRef

  3. 3
    Kai Chung Tse, Desmond Y. H. Yap, Colin S. O. Tang, Susan Yung, Tak Mao Chan, Response to adefovir or entecavir in renal allograft recipients with hepatitic flare due to lamivudine-resistant hepatitis B, Clinical Transplantation, 2010, 24, 2
  4. 4
    Ming-Jen Sheu, Hsing-Tao Kuo, Ching-Yih Lin, Lok-Beng Koay, Chuan Lee, Jyh-Jou Chen, Ling-Yu Tang, Sun-Lung Tsai, Lamivudine monotherapy for chronic hepatitis B infection with acute exacerbation revisited, European Journal of Gastroenterology & Hepatology, 2009, 21, 4, 447

    CrossRef

  5. 5
    Kai-Chung Tse, Susan Yung, Colin Tang, Terence Pok-Siu Yip, Tak Mao Chan, Management of hepatitis B reactivation in patients with lupus nephritis, Rheumatology International, 2009, 29, 11, 1273

    CrossRef

  6. 6
    Ming Shi, Junliang Fu, Feng Shi, Bin Zhang, Zirong Tang, Lei Jin, Zhenping Fan, Zheng Zhang, Liming Chen, Huifeng Wang, George K.K. Lau, Fu-Sheng Wang, Transfusion of autologous cytokine-induced killer cells inhibits viral replication in patients with chronic hepatitis B virus infection, Clinical Immunology, 2009, 132, 1, 43

    CrossRef

  7. 7
    Emmet B. Keeffe, Douglas T. Dieterich, Jean–Michel Pawlotsky, Yves Benhamou, Chronic Hepatitis B: Preventing, Detecting, and Managing Viral Resistance, Clinical Gastroenterology and Hepatology, 2008, 6, 3, 268

    CrossRef

  8. 8
    Jong-Kee Kim, Hyeon-Ji Lee, Young-Jo Lee, Jong-Yoon Chun, In-Kyoung Lee, Young-Suk Lim, Dong Jin Suh, Sun-Young Ko, Myeong Hee Kim, Heung-Bum Oh, Direct detection of lamivudine-resistant hepatitis B virus mutants by a multiplex PCR using dual-priming oligonucleotide primers, Journal of Virological Methods, 2008, 149, 1, 76

    CrossRef

  9. 9
    Ji Eun Uhm, Kihyun Kim, Tae Kyu Lim, Byeong-Bae Park, Sarah Park, Yong Sang Hong, Sang Cheol Lee, In Gyu Hwang, Kwang Cheol Koh, Mark H. Lee, Jin Seok Ahn, Won Seog Kim, Chul Won Jung, Won Ki Kang, Changes in Serologic Markers of Hepatitis B Following Autologous Hematopoietic Stem Cell Transplantation, Biology of Blood and Marrow Transplantation, 2007, 13, 4, 463

    CrossRef

  10. 10
    Scott K. Fung, Robert J. Fontana, Management of Drug-Resistant Chronic Hepatitis B, Clinics in Liver Disease, 2006, 10, 2, 275

    CrossRef

  11. 11
    Yun-Fan Liaw, The current management of HBV drug resistance, Journal of Clinical Virology, 2005, 34, S143

    CrossRef

  12. 12
    S. Gaia, A. Marzano, A. Smedile, V. Barbon, M. L. Abate, A. Olivero, M. Lagget, S. Paganin, M. Fadda, G. Niro, M. Rizzetto, Four years of treatment with lamivudine: clinical and virological evaluations in HBe antigen-negative chronic hepatitis B, Alimentary Pharmacology & Therapeutics, 2004, 20, 3
  13. 13
    Tak Mao Chan, Kai Chung Tse, Colin S. O. Tang, Kar Neng Lai, Stephen K. N. Ho, Prospective Study on Lamivudine-Resistant Hepatitis B in Renal Allograft Recipients, American Journal of Transplantation, 2004, 4, 7
  14. 14
    James R Jacob, Brent E Korba, Paul J Cote, Ilia Toshkov, William E Delaney IV, John L Gerin, Bud C Tennant, Suppression of lamivudine-resistant B-domain mutants by adefovir dipivoxil in the woodchuck hepatitis virus model, Antiviral Research, 2004, 63, 2, 115

    CrossRef

  15. 15
    George K.K Lau, Harry H.Y Yiu, Daniel Y.T Fong, Hoi-Ching Cheng, Wing-Yan Au, Lydia S.F Lai, Micheal Cheung, Hai-Ying Zhang, Albert Lie, Roger Ngan, Raymond Liang, Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy, Gastroenterology, 2003, 125, 6, 1742

    CrossRef

  16. 16
    Shing-yan Ma, George K.K. Lau, Vincent C.C. Cheng, Raymond Liang, Hepatitis B Reactivation in Patients Positive for Hepatitis B Surface Antigen Undergoing Autologous Hematopoietic Cell Transplantation, Leukemia & Lymphoma, 2003, 44, 8, 1281

    CrossRef

  17. 17
    Larry G. Birkenmeyer, Viral Hepatitis: Molecular Biology, Diagnosis, Epidemiology and Control, 2003,

    CrossRef

  18. 18
    YUN-FAN LIAW, Management of YMDD mutations during lamivudine therapy in patients with chronic hepatitis B, Journal of Gastroenterology and Hepatology, 2002, 17,
  19. 19
    Y.-F. Liaw, Therapy of chronic hepatitis B: current challenges and opportunities, Journal of Viral Hepatitis, 2002, 9, 6
  20. 20
    Yong Han Paik, Hyo Young Chung, Wang-Shick Ryu, Kwan Sik Lee, Ji Sook Lee, Jung Hee Kim, Chun Kyun Lee, Chae Yoon Chon, Young Myoung Moon, Kwang-Hyub Han, Emergence of YMDD motif mutant of hepatitis B virus during short-term lamivudine therapy in South Korea, Journal of Hepatology, 2001, 35, 1, 92

    CrossRef

  21. 21
    Edward Doo, T.Jake Liang, Molecular anatomy and pathophysiologic implications of drug resistance in hepatitis B virus infection, Gastroenterology, 2001, 120, 4, 1000

    CrossRef

  22. 22
    Anat Fisher, Vijaya M Musini, Ken Bassett, Antiviral treatments for lamivudine-resistant chronic hepatitis B adult patients, The Cochrane Library,
  23. 23
    Piero Luigi Almasio, Calogero Cammà, Vito Di Marco, Antonio Craxì, Hepatitis B: Prognosis and Treatment,